home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Turning Point Therapeutics to Participate in 38th Annual J.P. Morgan Healthcare Conference
Turning Point Therapeutics to Participate in 38th Annual J.P. Morgan Healthcare Conference
Post navigation
Previous Post
Previous
Kura Oncology Receives Fast Track Designation for Tipifarnib in HRAS Mutant HNSCC and Provides Enrollment Guidance for AIM-HN Trial
Next Post
Next
Neon Therapeutics Submits European Clinical Trial Authorization Application for Personal Neoantigen-Targeted T Cell Therapy NEO-PTC-01